Study on the Performance and Safety of Sentinox in COVID-19 Patients
NCT04909996
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
57
Enrollment
OTHER
Sponsor class
Conditions
COVID-19 (SARS-CoV-2 Infection)
Interventions
DEVICE:
Sentinox--Group A
DEVICE:
Sentinox--Group B
Sponsor
APR Applied Pharma Research s.a.